Follow
Wim Hennink
Wim Hennink
Professor, Department of Pharmaceutics, Utrecht University, The Netherlands
Verified email at uu.nl
Title
Cited by
Cited by
Year
Novel crosslinking methods to design hydrogels
WE Hennink, CF van Nostrum
Advanced drug delivery reviews 64, 223-236, 2012
31792012
25th anniversary article: engineering hydrogels for biofabrication
J Malda, J Visser, FP Melchels, T Jüngst, WE Hennink, WJA Dhert, J Groll, ...
Advanced materials 25 (36), 5011-5028, 2013
18992013
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress
T Lammers, F Kiessling, WE Hennink, G Storm
Journal of controlled release 161 (2), 175-187, 2012
15302012
Reduction-sensitive polymers and bioconjugates for biomedical applications
F Meng, WE Hennink, Z Zhong
Biomaterials 30 (12), 2180-2198, 2009
12082009
Cationic polymer based gene delivery systems
SC De Smedt, J Demeester, WE Hennink
Pharmaceutical research 17, 113-126, 2000
11772000
Hydrogels for protein delivery
T Vermonden, R Censi, WE Hennink
Chemical reviews 112 (5), 2853-2888, 2012
11672012
Polymeric micelles in anticancer therapy: targeting, imaging and triggered release
C Oerlemans, W Bult, M Bos, G Storm, JFW Nijsen, WE Hennink
Pharmaceutical research 27, 2569-2589, 2010
10892010
Hydrogels in a historical perspective: From simple networks to smart materials
SJ Buwalda, KWM Boere, PJ Dijkstra, J Feijen, T Vermonden, ...
Journal of controlled release 190, 254-273, 2014
10242014
Theranostic nanomedicine
T Lammers, S Aime, WE Hennink, G Storm, F Kiessling
Accounts of chemical research 44 (10), 1029-1038, 2011
9702011
Protein instability in poly (lactic-co-glycolic acid) microparticles
M van de Weert, WE Hennink, W Jiskoot
Pharmaceutical research 17, 1159-1167, 2000
8972000
Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment
O Naksuriya, S Okonogi, RM Schiffelers, WE Hennink
Biomaterials 35 (10), 3365-3383, 2014
8882014
Chitosan-based delivery systems for protein therapeutics and antigens
M Amidi, E Mastrobattista, W Jiskoot, WE Hennink
Advanced drug delivery reviews 62 (1), 59-82, 2010
7662010
In situ gelling hydrogels for pharmaceutical and biomedical applications
SR Van Tomme, G Storm, WE Hennink
International journal of pharmaceutics 355 (1-2), 1-18, 2008
7522008
Identification of formaldehyde-induced modifications in proteins: reactions with model peptides
B Metz, GFA Kersten, P Hoogerhout, HF Brugghe, HAM Timmermans, ...
Journal of Biological Chemistry 279 (8), 6235-6243, 2004
7342004
Tumour-targeted nanomedicines: principles and practice
T Lammers, WE Hennink, G Storm
British journal of cancer 99 (3), 392-397, 2008
6942008
Sheddable coatings for long-circulating nanoparticles
B Romberg, WE Hennink, G Storm
Pharmaceutical research 25, 55-71, 2008
6542008
Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications
F Van De Manakker, T Vermonden, CF Van Nostrum, WE Hennink
Biomacromolecules 10 (12), 3157-3175, 2009
5702009
Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing
NE Fedorovich, J Alblas, JR de Wijn, WE Hennink, AJ Verbout, WJA Dhert
Tissue engineering 13 (8), 1905-1925, 2007
5612007
Biodegradable polymers as non-viral carriers for plasmid DNA delivery
J Luten, CF van Nostrum, SC De Smedt, WE Hennink
Journal of Controlled Release 126 (2), 97-110, 2008
5602008
Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery
CJF Rijcken, O Soga, WE Hennink, CF Van Nostrum
Journal of controlled release 120 (3), 131-148, 2007
5542007
The system can't perform the operation now. Try again later.
Articles 1–20